EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Use of nicotine pouches among adults who currently or formerly smoked cigarettes and/or vaped nicotine: findings from the 2022 and 2024 US ITC smoking and vaping surveys

Shannon Gravely, Mary Hrywna, Gang Meng, Andrew Hyland, K Michael Cummings, Geoffrey T Fong, Cristine D Delnevo

Tobacco Control · 2025-11-07 · tc-2025-059556

DOI: 10.1136/tc-2025-059556 ↗
AstrattDettalji biblijografiċi

Astratt

Background Nicotine pouches (NPs) are one of the fastest growing tobacco product categories in the United States (US). We estimated the prevalence of NP use in 2022 and 2024 among US adults with established nicotine product use. Methods Data are from the 2022 (n=2087) and 2024 (n=2083) US ITC Smoking and Vaping Surveys. A nationally representative sample of adults (≥18 years) who smoked cigarettes and/or vaped nicotine or quit smoking and/or vaping completed at least one survey. Using weighted data, generalised estimating equation models were applied to estimate ever-use and current use (≥monthly). Data from both surveys were pooled to examine characteristics related to NP ever-use and current use. Results Between 2022 and 2024, the prevalence of NP ever-use increased by 42% (16.1%–22.8%, p

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →